Recombinant GM-CSF enhances the bactericidal ability of PMNs by increasing intracellular IL-1β and improves the prognosis of secondary Pseudomonas aeruginosa pneumonia in sepsis
Journal of Leukocyte Biology · 26.10.2023 · 114 (5) · 443-458
DOI: 10.1093/jleuko/qiad088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 25.07.2023. Verfasst von Fuquan Tu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, 2…. Hauptthemen laut MEDLINE: Granulocyte-Macrophage Colony-Stimulating Factor, Sepsis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fujian Provincial Natural Science Foundation of China.
Themen: Sepsis
Abstract (Originalsprache)
This study tested the hypothesis that recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances polymorphonuclear neutrophils (PMNs) via interleukin (IL)-1β to improve the prognosis of secondary infection in sepsis. The latter stage of sepsis is prone to induce immunosuppression, resulting in secondary fatal infections. Recombinant GM-CSF has become a way for sepsis-induced immunosuppression due to its immunomodulatory effect. However, the functional impact of GM-CSF on PMNs in sepsis remains obscure. This study aimed to study the role of recombinant GM-CSF on the bactericidal ability of PMNs in septic mice, assessing its effect on the prognosis of secondary pneumonia, and explore the mechanism of recombinant GM-CSF by intervening PMNs in patients with sepsis. The C57BL/6J sepsis mouse model was induced by cecal ligation and puncture. Recombinant murine GM-CSF (rmGM-CSF) was used in vivo when mice developed immunosuppression, which was characterized by abnormal bactericidal function of PMNs in peripheral blood. rmGM-CSF improved the prognosis of secondary pneumonia and reversed the function of PMNs. PMNs isolated by Percoll from septic patients were treated by recombinant human GM-CSF (rhGM-CSF) in vitro. The expression of CD11b, reactive oxygen species, phagocytosis, and neutrophil extracellular trap release in PMNs were enhanced by rhGM-CSF treatments. Whole-transcriptomic sequencing of mouse PMNs indicated that recombinant GM-CSF increased the expression of Il1b gene in PMNs. Blocking and inhibiting IL-1β release effectively counteracted the enhancing effect of GM-CSF on the bactericidal function of PMNs. rmGM-CSF enhances the bactericidal function of PMNs in vivo and improves the prognosis of secondary pneumonia in septic mice, and recombinant GM-CSF increases IL-1β precursor reserves, which, if stimulated, can rapidly enhance the bactericidal capacity of PMNs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou 350001, Fujian, China.
- Department of Emergency Intensive Care Unit, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou 350001, Fujian, China.
- Union Clinical Medical Colleges, Fujian Medical University, 29 Xinquan Road, Fuzhou 350001, Fujian, China.
ORCID-Profile: Fuquan Tu
Förderung
- National Natural Science Foundation of China
- Fujian Provincial Natural Science Foundation of China
Zitieren
APA
Tu, F., Pan, L., Wu, W., Cai, Y., Li, J., Wang, X., Lai, X., Chen, Z., Ye, L., & Wang, S. (2023). Recombinant GM-CSF enhances the bactericidal ability of PMNs by increasing intracellular IL-1β and improves the prognosis of secondary Pseudomonas aeruginosa pneumonia in sepsis. Journal of Leukocyte Biology, 114(5), 443-458. https://doi.org/10.1093/jleuko/qiad088
Vancouver
Tu F, Pan L, Wu W, Cai Y, Li J, Wang X, et al. Recombinant GM-CSF enhances the bactericidal ability of PMNs by increasing intracellular IL-1β and improves the prognosis of secondary Pseudomonas aeruginosa pneumonia in sepsis. Journal of Leukocyte Biology. 2023;114(5):443-458. doi:10.1093/jleuko/qiad088
BibTeX
@article{Tu2023,
author = {Tu, Fuquan and Pan, Lili and Wu, Wenwei and Cai, Yuanhua and Li, Jinggang and Wang, Xuechun and Lai, Xiaolin and Chen, Zhixiang and Ye, Luya and Wang, Shaoyuan},
title = {Recombinant GM-CSF enhances the bactericidal ability of PMNs by increasing intracellular IL-1β and improves the prognosis of secondary Pseudomonas aeruginosa pneumonia in sepsis},
journal = {Journal of Leukocyte Biology},
year = {2023},
volume = {114},
number = {5},
pages = {443--458},
doi = {10.1093/jleuko/qiad088}
}
EUVIMED